Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Co-codamol 30/500 capsules |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
|
|
Co-codamol 30/500 effervescent tablets |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
|
|
Co-codamol 30/500 tablets |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
|
|
Co-Cyprindiol 2000/35 | ||
|
|
Co-danthramer capsules |
For terminally ill patients |
|
|
|
Co-danthramer suspension |
For terminally ill patients |
|
|
|
Co-danthrusate capsules |
For terminally ill patients |
|
|
|
Co-magaldrox suspension |
Second line - when a lower sodium content is required. High relative cost. |
|
|
|
Codeine phosphate | ||
|
|
Codeine phosphate 25mg/5ml syrup |
